Chattaweelarp, T.; Changpradub, D.; Punyawudho, B.; Thunyaharn, S.; Santimaleeworagun, W.
Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics 2020, 9, 672.
https://doi.org/10.3390/antibiotics9100672
AMA Style
Chattaweelarp T, Changpradub D, Punyawudho B, Thunyaharn S, Santimaleeworagun W.
Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics. 2020; 9(10):672.
https://doi.org/10.3390/antibiotics9100672
Chicago/Turabian Style
Chattaweelarp, Thanawat, Dhitiwat Changpradub, Baralee Punyawudho, Sudaluck Thunyaharn, and Wichai Santimaleeworagun.
2020. "Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections" Antibiotics 9, no. 10: 672.
https://doi.org/10.3390/antibiotics9100672
APA Style
Chattaweelarp, T., Changpradub, D., Punyawudho, B., Thunyaharn, S., & Santimaleeworagun, W.
(2020). Is Early Monitoring Better? Impact of Early Vancomycin Exposure on Treatment Outcomes and Nephrotoxicity in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics, 9(10), 672.
https://doi.org/10.3390/antibiotics9100672
